Abstract:BACKGROUND: Growing animal evidence demonstrates that prolonged exposure to propofol during brain development induces widespread neuronal cell death, but there is little information on the role of astrocytes. Astrocytes can release neurotrophic growth factors such as brain-derived neurotrophic factor (BDNF), which can exert the protective effect on neurons in paracrine fashion. We hypothesize that during propofol anesthesia, BDNF released from developing astrocytes may not be sufficient to prevent propofol-induced neurotoxicity. METHODS: Hippocampal astrocytes and neurons isolated from neonatal Sprague Dawley rats were exposed to propofol at a clinically relevant dose of 30 &mgr;M or dimethyl sulfoxide as control for 6 hours. Propofol-induced cell death was determined by propidium iodide (PI) staining in astrocyte-alone cultures, neuron-alone cultures, or cocultures containing either low or high density of astrocytes (1:9 or 1:1 ratio of astrocytes to neurons ratio [ANR], respectively). The astrocyte-conditioned medium was collected 12 hours after propofol exposure and measured by protein array assay. BDNF concentration in astrocyte-conditioned medium was quantified using enzyme-linked immunosorbent assay. Neuron-alone cultures were treated with BDNF, tyrosine receptor kinase B inhibitor cyclotraxin-B, glycogen synthase kinase 3&bgr; (GSK3&bgr;) inhibitor CHIR99021, or mitochondrial fission inhibitor Mdivi-1 before propofol exposure. Western blot was performed for quantification of the level of protein kinase B and GSK3&bgr;. Mitochondrial shape was visualized through translocase of the outer membrane 20 staining. RESULTS: Propofol increased cell death in neurons by 1.8-fold (% of PI-positive cells [PI%] = 18.6; 95% confidence interval [CI], 15.2–21.9, P < .05) but did not influence astrocyte viability. The neuronal death was attenuated by a high ANR (1:1 cocultures; fold change [FC] = 1.17, 95% CI, 0.96–1.38, P < .05), but not with a low ANR [1:9 cocultures; FC = 1.87, 95% CI, 1.48–2.26, P > .05]). Astrocytes secreted BDNF in a cell density-dependent way and propofol decreased BDNF secretion from astrocytes. Administration of BDNF, CHIR99021, or Mdivi-1 significantly attenuated the propofol-induced neuronal death and aberrant mitochondria in neuron-alone cultures (FC = 0.8, 95% CI, 0.62–0.98; FC = 1.22, 95% CI, 1.11–1.32; FC = 1.35, 95% CI, 1.16–1.54, respectively, P < .05) and the cocultures with a low ANR (1:9; FC = 0.85, 95% CI, 0.74–0.97; FC = 1.08, 95% CI, 0.84–1.32; FC = 1.25, 95% CI, 1.1–1.39, respectively, P < .05). Blocking BDNF receptor or protein kinase B activity abolished astrocyte-induced neuroprotection in the cocultures with a high ANR (1:1). CONCLUSIONS: Astrocytes attenuate propofol-induced neurotoxicity through BDNF-mediated cell survival pathway suggesting multiple neuroprotective strategies such as administration of BDNF, astrocyte-conditioned medium, decreasing mitochondrial fission, or inhibition of GSK3&bgr;.

Intracellular Ca2+ Homeostasis And Jak1/Stat3 Pathway Are Involved In The Protective Effect Of Propofol On Bv2 Microglia Against Hypoxia-Induced Inflammation And Apoptosis

Abstract T P84: Neuroprotective Effect of Probenecid in a Rat Model of Transient Global Cerebral Ischemia-Reperfusion

Effect of Propofol on Mucous Permeability and Inflammatory Mediators Expression in the Intestine Following Traumatic Brain Injury in Rats

The protective effects of propofol against CoCl 2 -induced HT22 cell hypoxia injury via PP2A/CAMKIIα/nNOS pathway

Propofol Improved Hypoxia‐impaired Integrity of Blood‐brain Barrier Via Modulating the Expression and Phosphorylation of Zonula Occludens‐1

The protective effect of propofol against TNF-α-induced apoptosis was mediated via inhibiting iNOS/NO production and maintaining intracellular Ca 2+ homeostasis in mouse hippocampal HT22 cells.

Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling

Propofol Protects Against TNF-α-induced Blood-brain Barrier Disruption via the PIM-1/eNOS/NO Pathway

Propofol Ameliorates Microglia Activation by Targeting MicroRNA-221/222-IRF2 Axis

Propofol pretreatment reduces ceramide production and attenuates intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion in rats.

Propofol inhibits neuroinflammation and metabolic reprogramming in microglia in vitro and in vivo

Propofol Attenuates Inflammatory Response in LPS-Activated Microglia by Regulating the miR-155/SOCS1 Pathway

Propofol Attenuates Tnf-Alpha-Induced Mmp-9 Expression In Human Cerebral Microvascular Endothelial Cells By Inhibiting Ca2+/Camk Ii/Erk/Nf-Kappa B Signaling Pathway

Propofol Pretreatment Prevents Oxygen-Glucose Deprivation/Reoxygenation (OGD/R)-induced Inflammation Through Nuclear Transcription Factor κB (NF-κB) Pathway in Neuroblastoma Cells

Insufficient Astrocyte-Derived Brain-Derived Neurotrophic Factor Contributes to Propofol-Induced Neuron Death Through Akt/Glycogen Synthase Kinase 3β/mitochondrial Fission Pathway.

Mechanisms of Propofol Attenuation of Ketamine-Induced Neonatal Brain Injury

Propofol Attenuates TNF-α-induced MMP-9 Expression in Human Cerebral Microvascular Endothelial Cells by Inhibiting Ca2+/CAMK II/ERK/NF-κB Signaling Pathway.

Propofol maintains Th17/Treg cell balance and reduces inflammation in rats with traumatic brain injury via the miR‑145‑3p/NFATc2/NF‑κB axis

An in vitro study of the neuroprotective effect of propofol on hypoxic hippocampal slice.

Propofol ameliorates ischemic brain injury by blocking TLR4 pathway in mice

Wnt/β-catenin Signaling Pathway Contributes to Isoflurane Postconditioning Against Cerebral Ischemia-Reperfusion Injury and is Possibly Related to the Transforming Growth Factorβ1/smad3 Signaling Pathway.